Cytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Rating of Moderate Buy by Analysts

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 1-year target price among analysts […]

Related Keywords

United States ,Maryland ,America ,Johnt Henderson ,Fady Ibraham Malik ,Mutual Of America Capital Management ,Third Bancorp ,Cytokinetics Incorporated ,Securities Exchange Commission ,Fifth Third Bancorp ,Quadrant Capital Group ,Financial Services Group Inc ,Barclays ,Get Free Report ,Truist Financial ,Director John ,Exchange Commission ,Ibraham Malik ,State Retirement ,Pension System ,Capital Group ,America Capital Management ,Services Group ,Stock Down ,Get Free ,Cytokinetics Daily ,